Quadrant Biosciences
Quadrant Biosciences has developed cutting-edge saliva tests for the COVID-19 virus, autism and concussions

Quadrant Biosciences

The Extraordinary CNY Company You Probably Haven’t Heard Of By Ken Sturtz Richard Uhlig is the founder and chief executive officer of Quadrant Biosciences. The company has been in the news because of the saliva test it created to detect the coronavirus. “We intentionally kept a fairly low profile,” Uhlig says. “The work we’re doing is very novel technology.” Richard Uhlig’s idea for what would become a game-changing diagnostic testing company began by chance at a hockey rink in Upstate New York. After a successful career as a Wall Street executive, Uhlig and his wife moved to Ithaca to raise their three boys. In 2014, their youngest son sustained a fairly serious concussion playing ice hockey. When Uhlig learned about the diagnosis and management for concussions like his son’s, he thought it was archaic. Doctors diagnose concussions using tools such as neurological exams, cognitive testing and imaging tests. But there’s no quick and simple way to test for a concussion. Uhlig — who grew up in Jefferson County and studied biology at Cornell University before entering finance — thought there must be a better way of diagnosing concussions. He ended up spending six months reading 20 years of clinical research

This content is restricted to site members. You need to subscribe. $21.50 for one year, $35 for two years. You also receive three free guide with their subscription – CNY Summer Guide, CNY Winter Guide and CNY Business Guide. If you are an existing user, please log in. New users may register below.

Existing Users Log In